ketamine for depression
k

Johnson & Johnson’s $1.7 Billion Drug Success Signals Growth in Psychedelic Medicine Market

Johnson & Johnson’s Spravato, a nasal spray derived from ketamine, has reached blockbuster status with annual sales exceeding $1 billion. Approved in 2019 for...

Popular

United States to Reduce Troop Levels in Germany by 5,000

The United States has announced plans to reduce its...

PSG Returns to Ligue 1 Following Champions League Match Against Bayern Munich

Paris Saint-Germain is set to return to Ligue 1...

Johnson & Johnson’s $1.7 Billion Drug Success Signals Growth in Psychedelic Medicine Market

Johnson & Johnson’s Spravato, a nasal spray derived from...

Analysis of Key Trends and Indicators for the English Local Elections

England is holding extensive local elections, with thousands of...
spot_imgspot_imgspot_img
spot_imgspot_imgspot_imgspot_img